Ohio Personal Injury Lawyer Blog

This week, the Ohio State Highway Patrol has released more details in the trucking accident that killed three Marine recruits on their way to sign their final enlistment papers. According

A research studied published online last month in the BMJ (formerly the British Medical Journal), reported a strong correlation between who was paying a doctor and their opinions about whether

This blog is now located at http://rwkpersonalinjurylawyer.blogspot.com/. You will be automatically redirected in 30 seconds, or you may click here. For feed subscribers, please update your feed subscriptions tohttp://rwkpersonalinjurylawyer.blogspot.com/feeds/posts/default

Five men, a Marine Sergeant and four Marine recruits, were waiting at a traffic light when a semi truck impacted several other vehicles and sent their car careening into traffic

Toyota and its critics are deeply divided over the root cause of unintended acceleration problems. Toyota claims that the problems are mechanical, and has issued numerous recalls on the basis

On Tuesday, I talked about how noneconomic damage caps deny us our constitutional right as members of juries to make socially-contexted judgments about the price of the priceless. However, t

Yesterday, the Georgia Supreme Court struck down the state’s legislative cap on noneconomic damages in medical malpractice lawsuits. The Supreme Court relied on not only the authority of the Georgia

According to preliminary figures released by the National Highway Safety Traffic Safety Administration (NHTSA), motor vehicle accident fatalities on American highways dropped again in 2009 to the lowest number sinc

Last week, a California man described how his Toyota Prius experienced spontaneous acceleration, sending him on a harrowing ride on a winding California highway at speeds up to 90 m

When you drive with your kids and others in the car, it is your worst nightmare: a distracted driver causes a serious car accident, putting your children at risk. This

Avandia, a treatment for type 2 diabetes, was once the second-best-selling drug of GlaxoSmithKline (GSK), but sales have slipped as doctors and patients became concerned about the drug’s heart attack